NCT05789212

Brief Summary

The goal of this pilot study is to determine if a personalized trial testing a Mind-Body Intervention (MBI) can produce a meaningful increase in the average daily sleep duration among women 40-60 years of age working in healthcare. A total of 60 eligible participants will be randomized to one of two possible orders of treatment exposure comprised of three components: mindfulness, yoga, and guided walking, each assigned in 2-week block sequences for a total period of 12 weeks. The study will include a 2-week baseline period during which their baseline sleep duration and adherence to the Fitbit wear and survey submission will be assessed. Following the 2-week run-in period, participants deemed eligible and achieved at least 80% adherence of Fitbit wear and survey submission will be randomized to one of the two intervention arms. Exploratory aims include assessments of sleep quality, physiological factors and their direct and indirect relationships with participants' perceived stress, anxiety, and depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 29, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

May 22, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2025

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

February 2, 2026

Completed
Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

1.6 years

First QC Date

March 13, 2023

Results QC Date

December 17, 2025

Last Update Submit

January 15, 2026

Conditions

Keywords

Sleep durationSleep qualityAnxietyDepression

Outcome Measures

Primary Outcomes (1)

  • Mean Within-Subject Difference in Daily Sleep Duration

    The effect of the personalized MBI intervention on individual's sleep duration will be assessed in each arm separately. Participants' daily sleep duration will be measured objectively using Fitbit devices and by self-reported questionnaires. Individual changes in the average daily sleep durations between the run-in and each treatment period will be reported using means and 95% CIs. Bland-Altman plots will be constructed to visualize agreement between Fitbit reported and self-reported sleep duration. The effects of treatment on sleep duration will be assessed using GEE with an unstructured variance-covariance matrix for measures on the same day to that night's sleep. This model accounts for possible autocorrelation and linear trends between sleep duration across time. A change between time points is reported (e.g., baseline (2 weeks) and 2 weeks for each intervention period (4 weeks per intervention)) as a value for each intervention period minus value at baseline.

    Baseline (2 weeks) and 2 weeks for each intervention period (4 weeks total for each intervention)

Other Outcomes (6)

  • Mean Within-Subject Difference in Daily Sleep Latency

    13-16 weeks

  • Mean Within-Subject Difference in Daily Sleep Efficiency

    13-16 weeks

  • Mean Within-Subject Difference in Daily Resting Heart Rate

    13-16 weeks

  • +3 more other outcomes

Study Arms (2)

Personalized Trial ABCCBA

EXPERIMENTAL

Participants in Arm 1 will receive a Personalized Trial comprised of three components delivered in a ABCCBA sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.

Behavioral: Personalized Trial ABCCBA

Personalized Trial CBAABC

EXPERIMENTAL

Participants in Arm 2 will receive a Personalized Trial comprised of three components delivered in a CBAABC sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.

Behavioral: Personalized Trial CBAABC

Interventions

Participants will receive links for 30-minute videos for all three interventions, for 2 weeks each, 3 times per week, in a specified order (ABCCBA), where A-mindfulness, B-yoga, and C-guided walking.

Personalized Trial ABCCBA

Participants will receive links for 30-minute videos for all three interventions, for 2 weeks each, 3 times per week, in a specified order (CBAABC), where A-mindfulness, B-yoga, and C-guided walking.

Personalized Trial CBAABC

Eligibility Criteria

Age40 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women (biological sex at birth)
  • Age 40-60 years old
  • Northwell employee/affiliate
  • Self-reported history of short sleep duration (\<7h per 24-h period) for at least 3 months
  • After 2-week run-in, Fitbit-verified short sleep duration and ≥80% adherence of Fitbit wear and survey submission
  • Self-report of perceived stress ≥18 using the Perceived Stress Scale (PSS)
  • Access to and capable of using a smartphone
  • Can regularly wear a Fitbit device

You may not qualify if:

  • Men (biological sex at birth)
  • Age \< 40 or \>60 years old
  • Women who are pregnant
  • Not a Northwell employee/affiliate
  • No history of short sleep duration or non-adherent to the Fitbit wear and survey submission
  • Self-report of perceived stress \<18 using the Perceived Stress Scale (PSS)
  • Does not own or cannot regularly access a smartphone
  • Cannot regularly wear a Fitbit device
  • Unable to complete the study due to cognitive impairment, severe medical or mental illness, or active/prior substance abuse
  • Planned surgeries 6 months from study start date
  • Participants who have been previously told by a doctor/clinician they have mobility limiting health conditions and/or to not engage in walking 30 minutes, three times per week or yoga

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Health System Science

New York, New York, 10022, United States

Location

MeSH Terms

Conditions

Sleep DeprivationSleep Initiation and Maintenance DisordersAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

DyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersSleep Disorders, IntrinsicBehavioral SymptomsBehavior

Results Point of Contact

Title
Dr. Codruta Chiuzan
Organization
Northwell Health

Study Officials

  • Karina Davidson, PhD, MASc

    Northwell Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: Mixed between and within (Crossover) participant assignment. The study uses a between participant randomization; each of the two arms have a multiple crossover design (with different intervention orders to the crossover).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2023

First Posted

March 29, 2023

Study Start

May 22, 2023

Primary Completion

December 15, 2024

Study Completion

January 3, 2025

Last Updated

February 2, 2026

Results First Posted

February 2, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

All collected individual participant data (IPD) will be de-identified and pooled before sharing on the Open Science Framework, along with a data dictionary.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The study protocol, including the statistical analysis plan, will be made available in addition to the informed consent form following completion of recruitment but prior to publication of any data from the current study. De-identified, pooled individual participant data will be made available within a year of final participant data collection. We anticipate this data to be available on the Open Science Framework platform indefinitely.
Access Criteria
All data and supporting information will be stored on the Open Science Framework, a free web application with no access restrictions.

Locations